MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

227 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2021.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 73,860,328 shares of 93,104,451 outstanding shares and own 79.33% of the company stock.
Largest 10 shareholders include BlackRock Inc. (13,229,879 shares), VANGUARD GROUP INC (8,624,665 shares), EARNEST PARTNERS LLC (7,185,350 shares), STATE STREET CORP (4,034,657 shares), Camber Capital Management LP (3,000,000 shares), BANK OF AMERICA CORP /DE/ (2,745,892 shares), DIMENSIONAL FUND ADVISORS LP (2,730,879 shares), PFM Health Sciences, LP (2,718,623 shares), D. E. Shaw & Co., Inc. (2,659,707 shares), and GLENVIEW CAPITAL MANAGEMENT, LLC (2,569,433 shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.